Waters Corp (WAT) – aksjekurser og nyheter

WAT:NYSE

Waters Corp

374,41 USD

−0,66%

(−2,48) 1 D

374,41 USD

0,00% (0,00)

Etter stengetid

Stengt: 26. juni, 16:00:03 GMT-4 · USD

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for WAT …

Åpne

377,94 USD

Høy

379,73 USD

Lav

369,44 USD

Markedsverdi

36,76 mrd.

Snittvolum

964,29k

Volum

2,03 mill.

P/E-forhold

47,70

52 u høy

414,15 USD

52 u lav

275,05 USD

EPS

7,85 USD

Beta

1,21

Utestående aksjer

98,19 mill.

Antall ansatte

Åpne

377,94 USD

Høy

379,73 USD

Lav

369,44 USD

Markedsverdi

36,76 mrd.

Snittvolum

964,29k

Volum

2,03 mill.

P/E-forhold

47,70

52 u høy

414,15 USD

52 u lav

275,05 USD

EPS

7,85 USD

Beta

1,21

Utestående aksjer

98,19 mill.

Antall ansatte

Relaterte aksjer

Thermo Fisher Scientific

Nyhetssaker

Fra kilder på nettet

Ad-hoc-news.de

for 7 timer siden

Waters Corporation with a clear analyst view, shares trade steadily on the NYSE

Ad-hoc-news.de

for 2 døgn siden

Waters Corporation clears a fresh analyst mark, shares trade higher on Xetra and NYSE

Investing.com

for 2 døgn siden

Bernstein SocGen resumes Waters stock coverage with outperform rating

Profil

Waters Corporation is an American company headquartered in Milford, Massachusetts that provides analytical instruments and software used for chromatography, mass spectrometry, laboratory informatics, and rheometry by the life sciences, materials, and food industries. The company has primary manufacturing facilities in 9 U.S. locations as well as 11 international locations including Wexford, Wilmslow, Birmingham, Hüllhorst, Singapore, Bangalore, Beijing, and Shanghai. Major brands include ACQUITY UPC² / UPLC Systems and columns, Xevo mass spectrometry systems, Synapt MS / HDMS systems, Zodiac HPLC columns, XTerra HPLC columns, XBridge columns, Alliance HPLC systems, Empower chromatography software, MassLynx mass spectrometry software, Oasis sample preparation products, and NuGenesis lab management system. Its primary competitors are Agilent Technologies, Thermo Fisher Scientific, Revvity, and Danaher. Wikipedia

Om Waters Corp

Administrerende direktørUdit Batra

Ansatte7,9k

Grunnlagt1958

HovedkontorMilford, Massachusetts, USA

Sektor-

Nettstedwaters.com

Analytiker	Anbefaling	Handling	Prismål	Anslått	Dato
Eve Burstein Bernstein	Buy	Reiterated	435,00 USD	+16,2%	06/25/2026
Luke Sergott Barclays	Buy	Maintained	425,00 USD	+13,5%	06/24/2026
David Westenberg Piper Sandler	Hold	Initiated	400,00 USD	+6,8%	06/11/2026
Sidharth Sahoo HSBC	Buy	Maintained	435,00 USD	+16,2%	06/03/2026
Michael Ryskin Bank of America Securities	Hold	Reiterated	400,00 USD	+6,8%	06/02/2026
Michael Polark Wolfe Research	Buy	Maintained	425,00 USD	+13,5%	06/01/2026
Daniel Arias Stifel Nicolaus	Hold	Maintained	380,00 USD	+1,5%	05/18/2026
Brandon Couillard Wells Fargo	Hold	Maintained	370,00 USD	−1,2%	05/14/2026
Subbu Nambi Guggenheim	Buy	Reiterated	440,00 USD	+17,5%	05/11/2026
Justin Bowers Deutsche Bank	Hold	Maintained	350,00 USD	−6,5%	05/07/2026
Catherine Ramsey Schulte Robert W. Baird	Buy	Maintained	387,00 USD	+3,4%	05/06/2026
Casey Woodring J.P. Morgan	Hold	Reiterated	345,00 USD	−7,9%	05/06/2026
Lu Li UBS	Hold	Maintained	375,00 USD	+0,2%	05/06/2026
Evie Koslosky Goldman Sachs	Buy	Reiterated	380,00 USD	+1,5%	05/06/2026
Daniel Brennan TD Cowen	Hold	Reiterated	385,00 USD	+2,8%	05/06/2026
Kallum Titchmarsh Morgan Stanley	Hold	Maintained	350,00 USD	−6,5%	05/05/2026
Vijay Kumar Evercore ISI	Buy	Maintained	350,00 USD	−6,5%	05/05/2026
Matt Larew William Blair	Buy	Maintained	-	-	05/05/2026
Patrick B Donnelly Citi	Buy	Reiterated	425,00 USD	+13,5%	04/07/2026
Tycho Peterson Jefferies	Buy	Reiterated	470,00 USD	+25,5%	02/10/2026

Alle verdier i USD	juni 2025	sep. 2025	des. 2025	apr. 2026
Inntekt	771,33 mill.	799,89 mill.	932,36 mill.	1,27 mrd.
Varekostnad	321,41 mill.	327,81 mill.	362,86 mill.	679,00 mill.
Direkte driftskostnader	321,41 mill.	327,81 mill.	362,86 mill.	679,00 mill.
Utgifter til forskning og utvikling	48,55 mill.	53,64 mill.	46,90 mill.	95,00 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	187,26 mill.	187,23 mill.	195,78 mill.	305,00 mill.
Driftskostnader	247,71 mill.	252,97 mill.	254,76 mill.	552,00 mill.
Totale driftskostnader	569,12 mill.	580,77 mill.	617,62 mill.	1,23 mrd.
Driftsinntekter	202,21 mill.	219,11 mill.	314,74 mill.	36,00 mill.
Andre ikke-operasjonelle inntekter	−676,00k	−69,00k	2,06 mill.	1,00 mill.
EBT inkludert uvanlige elementer	177,69 mill.	170,12 mill.	264,18 mill.	−88,00 mill.
EBT uten uvanlige elementer	191,69 mill.	197,12 mill.	308,18 mill.	−5,00 mill.
Kostnad for inntektsskatt	30,58 mill.	21,20 mill.	38,97 mill.	−16,00 mill.
Faktisk avgiftssats	17,21 %	12,46 %	14,75 %	18,18 %
Andre driftskostnader	-	-	-	-
Nettoinntekt	147,11 mill.	148,92 mill.	225,21 mill.	−72,00 mill.
Netto fortjenestemargin	19,07 %	18,62 %	24,16 %	−5,68 %
Resultat per aksje	2,95	3,40	4,53	2,70
Rente- og investeringsinntekter	4,51 mill.	4,71 mill.	5,67 mill.	6,00 mill.
Rentekostnader	−14,35 mill.	−26,64 mill.	−14,29 mill.	−48,00 mill.
Netto rentekostnader	−9,85 mill.	−21,92 mill.	−8,62 mill.	−42,00 mill.
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	253,86 mill.	271,79 mill.	367,28 mill.	243,00 mill.
Gevinst eller tap ved salg av eiendeler	-	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning